Clinical Trial Update: A Study of PAD Followed by Autologous Stem Cell Transplantation (ASCT) to Treat Newly Diagnosed Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating progression after PAD induction followed by autologous stem cell transplantation in newly diagnosed multiple myeloma has been completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2018-08-10